Access cutting-edge non-hodgkin lymphoma treatment through this clinical trial at a research site in Newark. Study-provided care at no cost to qualified participants.
Access non-hodgkin lymphoma specialists in Newark at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-hodgkin lymphoma treatment provided free
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections). The purpose of this study is to assess the safety and tolerability of epcoritamab in combination with anti-neoplastic agents in adult participants with Non-Hodgkin lymphoma (NHL). Adverse events and change in disease activity will be assessed. Epcoritamab is an investigational drug being developed for the treatment of NHL. Study doctors put the participants in grou
Sponsor: Genmab
Check if you qualify for this non-hodgkin lymphoma clinical trial in Newark, DE
If you're searching for non-hodgkin lymphoma treatment options in Newark, DE, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Newark research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-hodgkin lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.